FindTrial
Sign In

Construction of solid organ transplantation database and biobank

Construction of solid organ transplantation database and biobank

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052682
Enrollment
Unknown
Registered
2021-11-03
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage disease of liver, kidney, heart and lung

Interventions

Case series:None

Sponsors

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adults and children undergoing various end-stage liver, kidney, heart and lung transplantation in the project unit from December 2021 to September 2022, including cadaver transplantation and living donor transplantation, with good postoperative compliance, taking anti rejection drugs and other combined drugs according to the doctor's instructions.

Exclusion criteria

Exclusion criteria: 1.Perioperative death or estimated survival time after transplantation is less than 3 months; 2.Patients or family members refused to sign informed consent.

Design outcomes

Primary

MeasureTime frame
follow-up data;—

Countries

Shanghai

Contacts

Public ContactXia Qiang

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

xiaqiang@medmail.com.cn+86 13661889035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026